drugset / Trial / NCT02734628

Pilot Study to Assess Number of Patients for Main Trial

NCT02734628

Phase 4 Completed 28 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study was to investigate the efficacy of Bepanthen® wound healing ointment compared to placebo in a superficial abrasive wound model. The primary objective was the re-epithelization at Day 5. The secondary objectives were re-epithelization at Days 2, 3, 4, 6, 7, 8, 9, 10 and 15, assessment of cosmetic outcome/acceptance at Day 15 (investigator only) and at Day 36 (investigator and subject), and documentation and analysis of safety parameters.

Timeline

Start
2007-03
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpanthenol Small molecule 15 mg Topical

Indications

No indication recorded.